Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Savoldo

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cellsEric Yvon, Michele Del Vecchio, Barbara Savoldo, et al.
Cancer Immunology Research|March 8, 2019
Cancer Immunotherapy with T Cells Carrying Bispecific Receptors That Mimic AntibodiesSarah Ahn, Jingjing Li, Chuang Sun, et al.
British Journal of Haematology|June 4, 2014
High throughput quantitative reverse transcription PCR assays revealing over-expression of cancer testis antigen genes in multiple myeloma stem cell-like side population cellsJianguo Wen, Hangwen Li, Wenjing Tao, et al.
Blood|October 4, 2003
Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applicationsAnn M Leen, Uluhan Sili, Barbara Savoldo, et al.
Cancer Research|July 26, 2014
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumorsNobuhiro Nishio, Iulia Diaconu, Hao Liu, et al.
Haematologica|December 18, 2012
Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host diseaseRikhia Chakraborty, Aruna Mahendravada, Serena K Perna, et al.
Nature Medicine|April 8, 2015
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytesIgnazio Caruana, Barbara Savoldo, Valentina Hoyos, et al.
Molecular Immunology|November 8, 2024
Preclinical assessment of the efficacy of B7-H3 CAR-T in renal cell carcinomaHuizhong Li, Fei Wang, Haifang Zhao, et al.
The Journal of Clinical Investigation|November 22, 2014
Survivin-specific T cell receptor targets tumor but not T cellsCaroline Arber, Xiang Feng, Harshal Abhyankar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 16, 2010
T cells expressing constitutively active Akt resist multiple tumor-associated inhibitory mechanismsJiali Sun, Gianpietro Dotti, Leslie E Huye, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cellsEric Yvon, Michele Del Vecchio, Barbara Savoldo, et al.
Cancer Immunology Research|March 8, 2019
Cancer Immunotherapy with T Cells Carrying Bispecific Receptors That Mimic AntibodiesSarah Ahn, Jingjing Li, Chuang Sun, et al.
British Journal of Haematology|June 4, 2014
High throughput quantitative reverse transcription PCR assays revealing over-expression of cancer testis antigen genes in multiple myeloma stem cell-like side population cellsJianguo Wen, Hangwen Li, Wenjing Tao, et al.
Blood|October 4, 2003
Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applicationsAnn M Leen, Uluhan Sili, Barbara Savoldo, et al.
Cancer Research|July 26, 2014
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumorsNobuhiro Nishio, Iulia Diaconu, Hao Liu, et al.
Haematologica|December 18, 2012
Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host diseaseRikhia Chakraborty, Aruna Mahendravada, Serena K Perna, et al.
Nature Medicine|April 8, 2015
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytesIgnazio Caruana, Barbara Savoldo, Valentina Hoyos, et al.
Molecular Immunology|November 8, 2024
Preclinical assessment of the efficacy of B7-H3 CAR-T in renal cell carcinomaHuizhong Li, Fei Wang, Haifang Zhao, et al.
The Journal of Clinical Investigation|November 22, 2014
Survivin-specific T cell receptor targets tumor but not T cellsCaroline Arber, Xiang Feng, Harshal Abhyankar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 16, 2010
T cells expressing constitutively active Akt resist multiple tumor-associated inhibitory mechanismsJiali Sun, Gianpietro Dotti, Leslie E Huye, et al.
Pageof 16